GAF Vault Sector Intelligence — Life Sciences

Unlocking Capital for Life Sciences.

Critical funding for clinical trials, biotech research, and medical hardware. GAF Vault's algorithmic engine is pre-configured for Life Sciences regulatory frameworks.

Real-Time Access

Start Life Sciences Assessment

Our scanner will cross-reference your specific R&D or expansion projects against the 2026 Life Sciences funding directives.

Launch Sector Scan
SECURE DATA LIVE MARKET DATA

Primary Incentive

Genome Canada / SR&ED

Canonical program targeting the Life Sciences core innovation layer.

Median Matching

$650,000 per SME

Average verifiable capital unlocked for Life Sciences firms in the 2024 cycle.

Industry Parameters

R&D Focused
High-Risk Offset
Patent Credits